Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?

The aim of the present study was to evaluate whether prostate cancer (PC) patients can be accurately classified on the bases of tissue expression of gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA). This retrospective study included 28 patients with PC. Formali...

Full description

Bibliographic Details
Main Authors: Pinuccia Faviana, Laura Boldrini, Paola Anna Erba, Iosè Di Stefano, Francesca Manassero, Riccardo Bartoletti, Luca Galli, Carlo Gentile, Massimo Bardi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
gastrin-releasing peptide receptor (GRPR)
prostate-specific membrane antigen (PSMA)
prostate cancer
multi-dimensional scaling (MDS)
Gleason score
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.650249/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.650249/full

Similar Items